Keywords
Last Name

John A. Meyers, PhD

TitleAssistant Professor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionResearch Implementation
Address650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Phone(617) 638-7543
ORCID ORCID Icon0000-0001-9560-5667
Other Positions
InstitutionBoston Medical Center

 Research Expertise & Professional Interests
Expertise includes: CLL; Leukemia; Lymphoid malignancies; B cell signaling; T cell development; Autoimmunity; cAMP signaling; Flow cytometry; Big Data anlaytics; and Informatics.

 Self-Described Keywords
  • immunology
  • phospho-flow
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Xu C, Wyman AR, Alaamery MA, Argueta SA, Ivey FD, Meyers JA, Lerner A, Burdo TH, Connolly T, Hoffman CS, Chiles TC. Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes. Int Immunopharmacol. 2016 Sep; 38:223-32. PMID: 27302770.
    View in: PubMed
  2. Tan Y, Watkins AA, Freeman BB, Meyers JA, Rifkin IR, Lerner A. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. J Immunol. 2015 Jan 1; 194(1):101-12. PMID: 25416804.
    View in: PubMed
  3. Meyers JA, Su DW, Lerner A. Chronic lymphocytic leukemia and B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors. J Immunol. 2009 May 1; 182(9):5400-11. PMID: 19380787.
    View in: PubMed
  4. Meyers JA, Taverna J, Chaves J, Makkinje A, Lerner A. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells. Clin Cancer Res. 2007 Aug 15; 13(16):4920-7. PMID: 17699872.
    View in: PubMed
  5. Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem. 2007 Jun 15; 282(24):17475-85. PMID: 17446175.
    View in: PubMed
  6. Everett PC, Meyers JA, Makkinje A, Rabbi M, Lerner A. Preclinical assessment of curcumin as a potential therapy for B-CLL. Am J Hematol. 2007 Jan; 82(1):23-30. PMID: 16947318.
    View in: PubMed
  7. Meyers JA, Mangini AJ, Nagai T, Roff CF, Sehy D, van Seventer GA, van Seventer JM. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine. 2006 Sep; 35(5-6):235-46. PMID: 17052915.
    View in: PubMed
John's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department